MD.USE

A computational solution for your experimental systems

Menu

  • Home
  • About us
  • AR,VR&3D-printing
    • OLLOMOL AR for CAPTISOL
    • OLLOMOL VR for CAPTISOL
  • Ad-hoc Services
  • Software development
    • Ollomol
    • Cyclo-lib
    • Cyclo Dance
    • Molvelle AR
  • News & Events
  • Contracts
  • Contact

Month: October 2017

MD.USE present in the Agrobiotech meeting

MD.USE, together with more than 200 representatives of companies and research centers in the biotechnology, agro-food and biomass sectors will be present at the Agrobiotech Innovation Meeting on 26 and 27 October, a biennial event that reaches the second edition

mdusewp 26/10/201726/10/2017 News Read more

Recent Posts

  • Cyclodextrin dimers: A versatile approach to optimizing encapsulation and their application to therapeutic extraction of toxic oxysterols
  • Remdesivir interactions with sulphobutylether-β-cyclodextrins: A case study using selected substitution patterns
  • Aggregation versus inclusion complexes to solubilize drugs with cyclodextrins. A case study using sulphobutylether-β-cyclodextrins and remdesivir
  • Underdog Pharmaceuticals Announces MD.USE Partnership and Technology Acquisition
  • MD.USE present in the Agrobiotech meeting

Recent Comments

    Archives

    • November 2021
    • October 2021
    • June 2020
    • October 2017
    • September 2017
    • November 2016
    • October 2016
    • August 2016

    Categories

    • News

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org

    News & Events

    Cyclodextrin dimers: A versatile approach to optimizing encapsulation and their application to therapeutic extraction of toxic oxysterols

    We have developed a novel class of specifically engineered, dimerized cyclodextrin (CD) nanostructures for the encapsulation of toxic biomolecules such as 7-ketocholesterol (7KC). 7KC accumulates over time and causes dysfunction in many cell types, linking it to several age-related diseases

    mduse 02/11/2021 News Read more

    Remdesivir interactions with sulphobutylether-β-cyclodextrins: A case study using selected substitution patterns

    Abstract Modified cyclodextrins (CDs) consist of a distribution of different structures with different number and location of the substituted groups. Among the most important applications of these molecules is their use as an enabling excipient in pharmaceutical formulations to provide

    mduse 02/11/2021 News Read more

    Aggregation versus inclusion complexes to solubilize drugs with cyclodextrins. A case study using sulphobutylether-β-cyclodextrins and remdesivir

    The formation of small hybrid aggregates between excipient and drug molecules is one of the mechanisms that contributes to the solubilization of active principles in pharmaceutical formulations. The characterization of the formation, governing interactions and structure of such entities is

    mduse 01/10/2021 News Read more
    Copyright © 2025 MD.USE Theme by: ThemeGrill Powered by: WordPress

    We are using cookies to give you the best experience on our website.

    You can find out more about which cookies we are using or switch them off in .

    MD.USE
    Powered by  GDPR Cookie Compliance
    Privacy Overview

    This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

    Strictly Necessary Cookies

    Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

    If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.